Entrada Therapeutics Inc (TRDA)
19.61
+0.24
(+1.24%)
USD |
NASDAQ |
Nov 27, 11:41
Entrada Therapeutics Shares Outstanding: 37.42M for Oct. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 31, 2024 | 37.42M |
September 30, 2024 | 37.40M |
July 31, 2024 | 37.20M |
June 30, 2024 | 37.17M |
June 25, 2024 | 37.13M |
April 30, 2024 | 33.76M |
April 16, 2024 | 33.68M |
March 31, 2024 | 33.60M |
March 06, 2024 | 33.60M |
December 31, 2023 | 33.44M |
October 31, 2023 | 33.37M |
September 30, 2023 | 33.34M |
July 31, 2023 | 33.27M |
June 30, 2023 | 33.21M |
April 30, 2023 | 33.20M |
April 11, 2023 | 33.19M |
March 31, 2023 | 33.18M |
Date | Value |
---|---|
February 28, 2023 | 33.08M |
February 09, 2023 | 33.02M |
December 31, 2022 | 31.39M |
October 31, 2022 | 31.41M |
September 30, 2022 | 31.33M |
July 31, 2022 | 31.37M |
June 30, 2022 | 31.28M |
April 30, 2022 | 31.37M |
April 05, 2022 | 31.36M |
March 31, 2022 | 31.26M |
February 28, 2022 | 31.25M |
December 31, 2021 | 31.22M |
November 30, 2021 | 31.21M |
November 05, 2021 | 31.25M |
November 02, 2021 | 29.89M |
October 29, 2021 | 29.89M |
October 25, 2021 | 28.31M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
28.31M
Minimum
Oct 25 2021
37.42M
Maximum
Oct 31 2024
32.85M
Average
33.13M
Median
Shares Outstanding Benchmarks
Catalyst Pharmaceuticals Inc | 119.27M |
Vertex Pharmaceuticals Inc | 257.53M |
Assembly Biosciences Inc | 6.356M |
Sarepta Therapeutics Inc | 95.52M |
Regenxbio Inc | 49.55M |